This vulnerability allows local attackers to escalate privileges on affected installations of Parallels Desktop 16.1.1-49141. An attacker must first obtain the ability to execute high-privileged code on the target guest system in order to exploit this vulnerability. The specific flaw exists within the Toolgate component. The issue results from the lack of proper validation of a user-supplied path prior to using it in file operations. An attacker can leverage this vulnerability to escalate privileges and execute code in the context of the current user on the host system. Was ZDI-CAN-12130.
Severity
CVSS 3.1
8.2 high
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
EPSS
0.6%(unchanged from 0.6% a week ago; 0.5% 30 days ago) estimated probability of exploitation activity in the next 30 days; 48th percentile. Scored 2026-11-21. A forecast for this CVE across the internet, not for your own systems.
CWE
CWE-22Improper Limitation of a Pathname to a Restricted Directory (Path traversal)
Show the promptExplain CVE-2021-27278 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2021-27278?via=ask-ai-copy and https://cve.bz/cve/CVE-2021-27278?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2021-27278 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.
Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.